Product Title: Handbook of Oxidative Stress in Cancer: Therapeutic Aspects (Original PDF from Publisher)
Format:
Publisher PDF, 85.5 MB
Overview (Details, Topics and Speakers):
By Sajal Chakraborti
This reference book, which is the second volume of Targeting Oxidative Stress in Cancer, explores oxidative stress as the potential therapeutic target for cancer therapy. The initial chapters discuss the molecular mechanisms of oxidative stress and its effects on different signaling pathways. Subsequently, the sections examine the impact of redox signaling on tumor cell proliferation and consider the therapeutic potential of dietary phytochemicals and nutraceuticals in reactive oxygen species (ROS)-induced cancer. In turn, it examines the evidence supporting the use of Vitamin C in cancer management, before presenting various synthetic and natural compounds that have therapeutic implications for oxidative stress-induced cancer. It also explores the correlation between non-coding RNA and oxidative stress. Furthermore, the book summarizes the role of stem cells in ROS-induced cancer therapy and reviews the therapeutic applications of nanoparticles to alter redox haemostasis in cancer cells. Lastly, it explores heat-shock proteins, ubiquitin ligases, and probiotics as potential therapeutic agents in ROS-mediated cancer. This book is a useful resource for basic and translational scientists as well as clinicians interested in the field of oxidative stress and cancer therapy.
Product details
- Publisher : Springer; 1st ed. 2022 edition (June 28, 2022)
- Language : English
- Paperback : 4200 pages
- ISBN-10 : 9811654239
- ISBN-13 : 978-9811654237
- ISBN-13 : 9789811654237
- eText ISBN: 9789811654220
Delivery Method
the Handbook of Oxidative Stress in Cancer: Therapeutic Aspects (Original PDF from Publisher) course/book will be provided for customer as download link. download link has NO Expiry and can be used anytime.
Contact Us
contact us to our email at support@med-cme.com or fill in the form below:
Reviews
There are no reviews yet.